#fdaalert — Public Fediverse posts

⚠️ Community Safety Alert

The FDA has upgraded a cheese recall to its most serious level after detecting Listeria bacteria in certain products.

If you buy packaged cheese, please review this update and share with others.

🔗 Full information here:
https://maalfreekaa.blogspot.com/2026/01/fda-cheese-recall-listeria-class-1.html

#FoodRecall #FDAAlert #CommunityHealth #ConsumerSafety #FoodAwareness

#MedicalAlert: #FDAAlert: Drug Safety Communication: Copaxone, Glatopa (glatiramer acetate) which is used to treat patients with multiple sclerosis
- FDA Adds Boxed Warning About a Rare but Serious Allergic Reaction Called
Anaphylaxis
https://www.drugs.com/fda/safety-communication-copaxone-glatopa-glatiramer-acetate-fda-adds-boxed-warning-rare-but-serious-14726.html?hash2=c290eb03ea67af9de2fe6fa1d6fc2964&utm_source=ddc&utm_medium=email&utm_campaign=FDA+Safety+Alert++Drug+Safety+Communication++Copaxone++Glatopa++glatiramer+acetate++++FDA+Adds+Boxed+Warning+About+a+Rare+but+Serious+Allergic+Reaction+Called+Anaphylaxis

#MedicalAlert: #FDAAlert: Drug Safety Communication: Copaxone, Glatopa (glatiramer acetate) which is used to treat patients with multiple sclerosis
- FDA Adds Boxed Warning About a Rare but Serious Allergic Reaction Called
Anaphylaxis
https://www.drugs.com/fda/safety-communication-copaxone-glatopa-glatiramer-acetate-fda-adds-boxed-warning-rare-but-serious-14726.html?hash2=c290eb03ea67af9de2fe6fa1d6fc2964&utm_source=ddc&utm_medium=email&utm_campaign=FDA+Safety+Alert++Drug+Safety+Communication++Copaxone++Glatopa++glatiramer+acetate++++FDA+Adds+Boxed+Warning+About+a+Rare+but+Serious+Allergic+Reaction+Called+Anaphylaxis

#MedicalAlert #FDAAlert: FDA Requires Guillain-Barré Syndrome (GBS) Warning in the Prescribing Information for RSV Vaccines Abrysvo and Arexvy https://www.drugs.com/fda/fda-requires-guillain-barr-syndrome-gbs-warning-rsv-vaccines-abrysvo-arexvy-14724.html?hash2=c290eb03ea67af9de2fe6fa1d6fc2964&utm_source=ddc&utm_medium=email&utm_campaign=FDA+Safety+Alert++FDA+Requires+Guillain+Barr+++Syndrome++GBS++Warning+in+the+Prescribing+Information+for+RSV+Vaccines+Abrysvo+and+Arexvy

#MedicalAlert #FDAAlert: FDA Requires Guillain-Barré Syndrome (GBS) Warning in the Prescribing Information for RSV Vaccines Abrysvo and Arexvy https://www.drugs.com/fda/fda-requires-guillain-barr-syndrome-gbs-warning-rsv-vaccines-abrysvo-arexvy-14724.html?hash2=c290eb03ea67af9de2fe6fa1d6fc2964&utm_source=ddc&utm_medium=email&utm_campaign=FDA+Safety+Alert++FDA+Requires+Guillain+Barr+++Syndrome++GBS++Warning+in+the+Prescribing+Information+for+RSV+Vaccines+Abrysvo+and+Arexvy